DNA

#Cancer drug targets #Clinical trial #DNA #Kairos Pharma #Prostate cancer #Stem cells #Tumour biology

Cancer drug resistance isn’t one problem, it’s many

Neil Bhowmick, Chief Scientific Officer at Kairos Pharma, explores the biology of cancer drug resistance and the opportunities to overcome it.  Despite extraordinary advancements in how we treat cancer, ranging from cytotoxic chemotherapy to precision immunotherapies, one fundamental barrier consistently impedes… Read More

#Cancer Research #Exclusive Content

Researcher pipetting samples in microplate
#ASGCT #DNA #Genetic medicines

Company shows ‘new therapeutic modality’ at ASGCT 2026 

Serif Biomedicines has announced preclinical data showing the potential of its Modified DNA as a new class of genetic medicines.  Results from non-human primates, announced at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting 2026, suggest Modified DNA could overcome barriers of innate immune… Read More

#News

Francis Crick Institute
#DNA #Genomics #The Francis Crick Institute

Crick set to open UK’s first ancient DNA exhibition 

The Francis Crick Institute is set to house the UK’s first ancient DNA exhibition exploring human evolution and disease.  The exhibition, set to open on 16 July 2026, is led by researchers at the Crick’s Ancient Genomics Laboratory.  ‘We Go Way Back’ will uncover findings from… Read More

#News

#CureLab Oncology #DNA #endogene.bio #Endometriosis #Genetics #Junevity #MHRA #Ocular diseases #Oncology #Regulatory #UK government #University of California San Francisco #Women's health

DDW Highlights: 20 January 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, new research in women’s health uncovered significant findings related to endometriosis and… Read More

#Podcasts

#CureLab Oncology #DNA #endogene.bio #Endometriosis #Genetics #Junevity #MHRA #Ocular diseases #Oncology #Ovarian cancer #Regulatory #UK government #University of California San Francisco #Women's health

This week in Drug Discovery (12 – 16 January) 

News round-up for 12 – 16 January by Bruno Quinney, Content Team at DDW.  This week in DDW, new research in women’s health has uncovered significant findings related to endometriosis and ovarian cancer. Elsewhere, can ageing be reversed?  The top stories:    Discovery reveals endometriosis is not… Read More

#News

Ovarian cancer cells
#CureLab Oncology #DNA #Oncology #Ovarian cancer

Therapy could increase ovarian cancer survival, paper finds 

A novel DNA-based therapy could increase survival rates for women with platinum-resistant ovarian cancer, a new paper reveals.  A new clinical study, published in the International Journal of Gynecological Cancer, shows the DNA-based therapy Elenagen, when administered in combination with standard chemotherapy drug gemcitabine, significantly extended overall survival… Read More

#Cancer Research #News

#DNA #Drug discovery #Single-cell analysis

New insight into DNA function offers hope for drug discovery

Scientists have captured the most detailed view yet of how DNA folds and functions inside living cells, which could provide new insights into gene regulation.  Researchers at the Radcliffe Department of Medicine, University of Oxford, used a new technique called MCC Ultra to map the human genome down to a… Read More

#News

#DNA #Drug therapy #Mitochondria

Drug therapies could prevent hereditary diseases, study finds

New drug therapies could be developed to prevent hereditary diseases, research reveals.  According to a study published in the latest issue of Science, researchers have pinpointed a cellular mechanism involved in the inheritance of genetic mutations. It is believed the findings could help develop treatments… Read More

#News

#Biotherapeutics #DNA #Drug discovery #Gut microbiome #Microbiome #Precision medicine #Synthetic biology #Synthetic DNA

Podcast: How is precision medicine making its mark in drug discovery?

This is the latest episode of the free DDW narrated podcast, titled “How is precision medicine making its mark in drug discovery?”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “Accelerating biotherapy and personalised medicine with long DNA”… Read More

#News

#AI / data analytics / healthtech / informatics #Cancer research #DNA #Genetics / genomics #Oncology #RNA #siRNA

New podcast: The revolutionary impact of understanding genomics

This is the latest episode of the free DDW narrated podcast, titled “The revolutionary impact of understanding genomics”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “Open science, genomics, and the quiet revolution in our approach to pharma” and “… Read More

#News

DNA sequencing
#Antibiotics #Bacteria #DNA #Gene sequencing #Infectious diseases #MHRA

DNA sequencing diagnoses bacterial infections faster

Scientists have developed a DNA sequencing approach that can be implemented in hospitals to diagnose bacterial infections faster and more accurately.  Developed by a UK team from Barts Health NHS Trust and the Medicines and Healthcare products Regulatory Agency (MHRA), the service is designed to help doctors… Read More

#Editor's Choice #News

Bone cancer
#Bone cancer #Cancer therapy #Chordoma #DNA #Drug discovery #Rare disease

New therapy to treat rare bone cancer chordoma

A paper published in Nature Communications by a team of researchers from Oxford and North Carolina provides structural insights into human brachyury DNA recognition and discovery of progressible binders for cancer therapy. Unpacking brachyury According to the paper’s abstract1, Brachyury is a transcription factor that affects tumour growth of the… Read More

#News

Telomeres on chromosomes
#DNA #Lung cancer #MAIA Biotechnology #Oncology #Phase II trial

Positive efficacy updates for Phase II trial in non-small cell lung cancer

MAIA Biotechnology has shared positive updated data from its THIO-101 Phase II clinical trial evaluating its lead candidate, THIO, in patients with advanced non-small cell lung cancer (NSCLC) who failed two or more standard-of-care therapy regimens.  In the trial, THIO was sequenced with Regeneron’s immune checkpoint inhibitor… Read More

#Cancer Research #News

Human liver
#American Association for the Study of Liver Diseases (AASLD) #DNA #Epigenomics #HBV #Liver disease #Tune Therapeutics #Viral hepatitis

Preclinical data suggests functional cure for HBV

Epigenome editing company Tune Therapeutics has showcased new data at the American Association for the Study of Liver Diseases (AASLD) conference, in support of its drive to develop a lasting, functional cure for chronic Hepatitis B Virus (HBV). Tune presented its lead HBV programme at the 2023 iteration of the… Read More

#News

mRNA
#Circio Holding #circular RNAs #DNA #Funding #mRNA #Norway #RNA #Viral vectors

NOK 10.7 million supports circular mRNA technology

Biotechnology company Circio Holding has secured approximately NOK 10.7 million (€907.4k) in financing to support the development of its circVec circular mRNA technology. The major allocations in the financing were to existing shareholders Høse AS and Bækkelaget Holding AS, and new shareholders Star Kapital AS (v/ Tom A Thorsen) and… Read More

#News